Casey Lynch - Net Worth and Insider Trading
Casey Lynch Net Worth
The estimated net worth of Casey Lynch is at least $1 Million dollars as of 2024-05-05. Casey Lynch is the CEO of Quince Therapeutics Inc and owns about 1,120,580 shares of Quince Therapeutics Inc (QNCX) stock worth over $1 Million. Details can be seen in Casey Lynch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Casey Lynch has not made any transactions after 2021-05-10 and currently still holds the listed stock(s).
Transaction Summary of Casey Lynch
Casey Lynch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Casey Lynch owns 2 companies in total, including Quince Therapeutics Inc (QNCX) , and Longboard Pharmaceuticals Inc (LBPH) .
Click here to see the complete history of Casey Lynch’s form 4 insider trades.
Insider Ownership Summary of Casey Lynch
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2021-05-10 | director & Chief Executive Officer |
| LBPH | Longboard Pharmaceuticals Inc | 2021-03-11 | director |
Casey Lynch Latest Holdings Summary
Casey Lynch currently owns a total of 1 stock. Casey Lynch owns 1,120,580 shares of Quince Therapeutics Inc (QNCX) as of May 10, 2021, with a value of $1 Million.
Latest Holdings of Casey Lynch
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2021-05-10 | 1,120,580 | 0.99 | 1,103,883 |
Holding Weightings of Casey Lynch
Casey Lynch Form 4 Trading Tracker
According to the SEC Form 4 filings, Casey Lynch has made a total of 3 transactions in Quince Therapeutics Inc (QNCX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Quince Therapeutics Inc is the sale of 30,000 shares on May 10, 2021, which brought Casey Lynch around $1 Million.
Insider Trading History of Casey Lynch
- 1
Casey Lynch Trading Performance
Casey Lynch Ownership Network
Casey Lynch Owned Company Details
What does Quince Therapeutics Inc do?
Who are the key executives at Quince Therapeutics Inc?
Casey Lynch is the director & Chief Executive Officer of Quince Therapeutics Inc. Other key executives at Quince Therapeutics Inc include Chief Scientific Officer Guenter Janhofer , President Charles S. Ryan , and director & Chief Executive Officer Dirk Thye .
Quince Therapeutics Inc (QNCX) Insider Trades Summary
Over the past 18 months, Casey Lynch made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 168,000 shares made by Dirk Thye , and a net purchase of 71,762 shares made by Brendan Hannah .
In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,871 shares of Quince Therapeutics Inc (QNCX) were sold and 748,198 shares were bought by its insiders, resulting in a net purchase of 746,327 shares.
Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Quince Therapeutics Inc Insider Transactions
Casey Lynch Mailing Address
Above is the net worth, insider trading, and ownership report for Casey Lynch. You might contact Casey Lynch via mailing address: C/o Cortexyme, Inc., 269 East Grand Ave., South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
